The recalled ibuprofen tablets may contain individual blistered doses labeled as oxcarbazepine tablets. AHP also recalled the oxcarbazepine tablets due to a mislabeled blister packaging which could result in patients receiving ibuprofen instead.
If a patient misses a dose of oxcarbazepine, used to treat certain type of epileptic seizures, the risk for a seizure increases. Additionally, if a patient accidently consumes ibuprofen, it may cause adverse reactions, according to the U.S. Food and Drug Administration notification regarding the recall.
More Articles on Recalls:
Baxter Initiates Worldwide Saline Solution Recall
5 Health IT Safety Issues Hospital Executives Should Monitor
OR Implants and the Case for Supply Chain Automation
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
